Abstract
Cholecystokinin (CCK) is a gastrointestinal hormone with potential therapeutic promise for obesity-diabetes. The present study examined the effects of twice daily administration of the N-terminally modified stable CCK-8 analogue, (pGlu-Gln)-CCK-8, on metabolic control and hypothalamic gene expression in high fat fed mice. Sub-chronic twice daily injection of (pGlu-Gln)-CCK-8 for 16 days significantly decreased body weight (p
Original language | English |
---|---|
Pages (from-to) | 471-473 |
Journal | HORMONE AND METABOLIC RESEARCH |
Volume | 45 |
Issue number | 6 |
DOIs | |
Publication status | Published (in print/issue) - 11 Jan 2013 |